Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03138889 · TERMINATED
Trial details
- NCT number
- NCT03138889
- Sponsor
- Nektar Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-09
- Primary completion
- 2022-07-05
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.